CTLA4 and neoplasm: Single agent anti-PD-1 or anti-CTLA-4 increased the infiltrating ICOS+ CD4+ T cells to a similar degree, but combination blockade interestingly had a greater effect on the percentage of tumor-infiltrating lymphocytes (TILs) composed of ICOS+ CD4+T cells (Figure 1B).